Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
MENU
Back to Top

NIA-AA Research Framework

Dear Colleague:

In 2011, the National Institute on Aging (NIA) at National Institutes of Health (NIH) and the Alzheimer's Association published revised guidelines (NIA-AA) for modernization of the diagnosis of Alzheimer's disease.

Starting in 2016, the NIA and Alzheimer's Association convened an international workgroup of scientific experts to re-evaluate the 2011 guidelines in the context of new and emerging data. The workgroup has proposed a framework for Alzheimer’s disease research which incorporates the latest understanding of biomarkers for research purposes. The framework updates a scheme for defining and staging the disease across its entire spectrum so that the research community can communicate findings in a common manner. The scheme was presented at Clinical Trials on Alzheimer's Disease (CTAD) 2016 and the Alzheimer's Association International Conference® (AAIC®) 2017. 

In response to feedback collected from those presentations and follow up discussions, the NIA-AA workgroup has continued to refine its thinking. To that end, we write to you today to share that an updated draft of the NIA-AA research framework is available on ALZ.org/NIA-AA for further review and further comment until December 2, 2017.

Sincerely, 

Alzheimer's Association

On behalf of the NIA-AA Workgroup

Acknowledgements

Acadia Pharmaceuticals Otsuka Pharmaceuticals Cambridge University Press Avanir Pharmaceuticals
CORPORATE COUNCILS

IPA

555 E. Wells St.
Suite 1100
Milwaukee, WI 53202
United States

Tel: +1.414.918.9889
Fax: +1.414.276.3349
E-mail: info@ipa-online.org

IPA Briefs

Sign up for IPA Briefs and receive the latest announcements from IPA.

© International Psychogeriatric Association. All rights reserved.